At this year’s BioAsia Taiwan (July 27–30, 2023, Nangang Exhibition Center), Glac Biotech once again proved why it is recognized as a global leader in probiotics. Over four days, the company’s booth became a hub of curiosity and conversation, where international clients and health industry professionals gathered to learn about Glac’s cutting-edge manufacturing technologies and exclusive probiotic powder production processes.
The excitement didn’t stop at the booth. During a special innovation seminar, Glac unveiled a unique solution designed for one of modern life’s most common challenges: the toll of late nights and social drinking. The presentation of PRONULIFE^® LvUCare sparked intense interest, as experts and brand representatives explored how this raw material helps combat metabolic syndrome by supporting gut health and restoring metabolic balance.

Innovation on Display: From Sleep Support to Postbiotics
Glac Biotech’s exhibition highlights drew widespread attention:

• PRONULIFE^® Sleep & Mood Probiotics captivated audiences looking for solutions to insomnia and depression, with many brands inquiring about OEM collaborations.

• Totipro^® postbiotics (PE0301 and PE0401), already celebrated on the international stage, became a magnet for inquiries from global giants, including companies from Hong Kong, Thailand, and India.
   

Visitors praised not only the functionality of these ingredients but also the fact that Glac’s manufacturing processes meet rigorous international standards — an essential factor for global probiotic partnerships.

Quality, Technology, and Integration
What set Glac apart at BioAsia Taiwan was its ability to combine scientific R&D with industrial-scale excellence. Through its proprietary PRONEX^® probiotic powder production technology and its PRIMETEK^® vertically integrated OEM service, Glac demonstrated how it ensures top-tier quality from strain selection to finished product.
With every custom project, Glac employs its innovative strain-screening platform, robust clinical data analysis, and stringent quality control systems to guarantee safety and efficacy. For clients, this translates into faster time-to-market, greater reliability, and sustainable long-term partnerships.

A Future Built on Collaboration
The 2023 BioAsia Taiwan exhibition wasn’t just about showcasing products — it was about forging connections. With enthusiastic responses from both domestic and international partners, Glac Biotech reinforced its role as the go-to expert for probiotics and postbiotics.
As demand for health solutions continues to rise, Glac remains committed to advancing science, investing in innovation, and delivering the highest-quality probiotic raw materials to meet the needs of consumers worldwide.